Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Interest Expenses (2016 - 2025)

BioCorRx's Interest Expenses history spans 15 years, with the latest figure at $193431.0 for Q3 2025.

  • For Q3 2025, Interest Expenses rose 29.82% year-over-year to $193431.0; the TTM value through Sep 2025 reached $445531.0, down 34.8%, while the annual FY2024 figure was $776780.0, 521.42% up from the prior year.
  • Interest Expenses for Q3 2025 was $193431.0 at BioCorRx, up from $36563.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $317907.0 in Q2 2024 and bottomed at -$242832.0 in Q3 2021.
  • The 5-year median for Interest Expenses is $36883.0 (2023), against an average of $73085.7.
  • The largest annual shift saw Interest Expenses crashed 293.64% in 2021 before it skyrocketed 1056.49% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $13599.0 in 2021, then skyrocketed by 74.59% to $23743.0 in 2022, then soared by 45.68% to $34588.0 in 2023, then skyrocketed by 270.23% to $128054.0 in 2024, then surged by 51.05% to $193431.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Interest Expenses are $193431.0 (Q3 2025), $36563.0 (Q2 2025), and $87483.0 (Q1 2025).